Berlin's advantages at a glance
- Highest concentration of researchers and academics in Germany (per capita);
- High productivity at low labor costs
- Excellent infrastructure throughout the capital region
- Attractive real estate in all locations
- Home of the Bundestag (Germany's parliament), the federal government, and of the top central industry associations
- Highly qualified and highly flexible labor force
- A science and research landscape that is unparalleled within Germany
- Efficient business networks and centers of excellence
- Family-friendly environment
- High quality of life
TRACK RECORD: Over 1,223 companies have located to Berlin or invested here between 2001 and 2011
(Source: Berlin Partner GmbH, 2011)
Investor services
Berlin Business Packages
























Why Berlin?
"We relocated our offices to Berlin because we were looking to cooperate more closely with people, and I don't mean just at the political level. Here, we have established many interesting contacts within the various scientific institutions, hospitals like the Charité and various biotech companies. I am confident that in future, we will be able to attract even more world-class scientific research to Berlin."
Dr. Andreas Penk, Chairman of the Management Board, Pfizer Deutschland GmbHWhy Berlin?
"The affordability of real estate along with the availability of well-trained, multi-lingual personnel are the reasons we chose to locate our business in Berlin."
Eggert Voscherau, Chairman of the Supervisory Board, BASF SEWhy Berlin?
"As Germany's largest newspaper, we have to accept Berlin's new role. To live in Berlin is to know the news first."
Kai Diekmann, Editor in Chief of the Bild NewspaperWhy Berlin?
"A shining national music scene, creative minds and international stars that love the city. As a market leader, we profit from Berlin’s endless potential and we’re set to generate even more musical highlights in the future."
Frank Briegmann, President & CEO of Universal Music GermanyWhy Berlin?
"The life science cluster in Berlin-Brandenburg offers SCIENION an attractive level of customer potential and excellent opportunities for cooperation. Our collaboration with other regional companies, such as MicroDiscovery and Invitek, and our work with research institutes, such as the MPI for Infectious Biology and the Fraunhofer Institute for Biomedical Engineering, enable us to produce a steady stream of product innovations."
Dr. Holger Eickhoff, CEO, SCIENION AGWhy Berlin?
"When Axel Springer AG emphatically affirmed its commitment to Berlin by moving its corporate headquarters to the capital, this was not just because the concept that our founder Axel Springer had of Berlin, as a new intellectual hub, is still as viable today as it was during his lifetime. It also happened because I am convinced that these decisions will bring our company long-term advantages, which will position us for both economic and publishing success in the future."
Dr. Mathias Döpfner, Chairman and CEO Axel Springer AG